Within a week, many pharmaceutical companies have reported reviews, including Shanghai Pharmaceuticals, Zhejiang Pharmaceuticals, etc.

[Pharmaceutical Network Industry News] In the past week, many pharmaceutical companies have issued announcements, and related products have passed the consistency evaluation of generic dru.
According to relevant national policies, drug varieties that have passed the consistency evaluation will receive greater support in the fields of medical insurance payment and procurement by medical institutio.
Therefore, product market competitiveness may be further enhanc.
Shanghai Pharmaceuticals: Folic Acid Tablets Passed Consistency Evaluation of Generic Drugs Shanghai Pharmaceuticals announced on August 4 that Changzhou Pharmaceutical Factory, a subsidiary of the company, recently received the "Approval Notice for Supplementary Drug Application" issued by the State Food and Drug Administrati.
Home through the quality and efficacy consistency evaluation of generic dru.
Folic acid is a B vitamin, a type of vitamin that maintains cell function, metabolism and grow.
Shanghai Pharmaceuticals stated in the announcement that the folic acid tablets of Changzhou Pharmaceutical Factory passed the consistency evaluation of generic drugs, which is conducive to improving market competitiveness, and at the same time accumulated valuable experience for the company's follow-up products to carry out generic drug consistency evaluati.
According to the IQVIA database, in 2021, the hospital purchase amount of the drug will be RMB 1841 milli.
In 2021, Changzhou Pharmaceutical Factory's sales revenue from the drug will be RMB 1032 milli.
Zhejiang Medicine: Ciprofloxacin Hydrochloride Tablets Pass Consistency Evaluation On August 4, Zhejiang Medicine announced that it has recently received the “Approval of Supplementary Drug Application for Ciprofloxacin Hydrochloride Tablets (25g)” approved and issued by the State Food and Drug Administrati.
Notice" to approve the drug to pass the quality and efficacy consistency evaluation of generic dru.
The data show that ciprofloxacin hydrochloride tablet is a third-generation quinolone antibacterial drug, which is suitable for the treatment of lower respiratory tract infection, cystic fibrosis or bronchiectasis in adults caused by Gram-negative bacteria, bronchopulmonary infection, pneumonia, Chronic suppurative otitis media, urinary tract infection, complicated urinary tract infection,e.
Up to now, Zhejiang Medicine has invested about 67 million yuan in research and development for the consistency evaluation of ciprofloxacin hydrochloride table.
Cortellis data query shows that the global sales of ciprofloxacin hydrochloride tablets in 2021 will be US$519 million; Min.
com data query shows that the domestic sales of ciprofloxacin hydrochloride tablets in 2021 will be 5891 million yu.
Yuekang Pharmaceutical: Azithromycin for Injection has passed the quality and efficacy consistency evaluation of generic dru.
Yuekang Pharmaceutical announced on August 3 that the company received the “Drug Supplement” approved and issued by the State Drug Administration on Azithromycin for Injection (5.
Application for Approval Notice (Notice .
: 2022B03103), the drug has passed the quality and efficacy consistency evaluation of generic dru.
Data show that azithromycin is a macrolide antibiot.
The antibacterial spectrum and antibacterial activity of these drugs are basically similar, and they have good antibacterial effects on most Gram-positive bacteria, Legionella, Chlamydia, Mycoplasma, and anaerobic bacter.
The data shows that the annual sales trend of sample hospitals in China (urban public) in 2021 shows that the sales of azithromycin for injection will be 4524 million yu.
Lifang Pharmaceutical: Felodipine Sustained-Release Tablets Passed Consistency Evaluation of Generic Drugs On August 3, Lifang Pharmaceutical announced that it had received the "Approval Notice for Supplementary Drug Application" for Felodipine Sustained-Release Tablets approved and issued by the State Drug Administrati.
(Notice .
: 2022B03112), the results show that the company's felodipine sustained-release tablets passed the quality and efficacy consistency evaluation of generic dru.
Data show that felodipine sustained-release tablets are mainly used for the treatment of hypertension and stable angina pector.
The product of Lifang Pharmaceutical obtained the approval for drug registration and production in 2004, the approval number is H20040773, and the specification is 5.
Whether it passes the consistency evaluation of generic drugs is one of the important indicators for the country to purchase drugs in a centralized mann.
China attaches great importance to the consistency evaluation of generic drugs, and establishes and improves the review technical standard system, and continuously optimizes the selection of reference preparatio.
The consistency evaluation work is progressing steadi.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.